HCA Healthcare stock heads to October 27 earnings with USD 19.33 billion forecast

Published on 10/21/2026 at 10:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Analysts see USD 6.66 earnings per share on USD 19.33 billion revenue. HCA Healthcare stock costs EUR 415.00 on October 21, 2026 before results.

Earnings setup and operating context

HCA Healthcare is scheduled to publish third-quarter results on October 27, 2026.
The hospital operator generated USD 20.23 billion in second-quarter revenue in 2026.
HCA Healthcare stock traded at EUR 415.00 at 10:48 a.m. CEST at Lang & Schwarz on October 21, 2026.

Zart aquarelliertes Krankengebäude mit Kirschblüten und einer sonnigen Stadtkulisse im Hintergrund — HCA Healthcare US40412C1018 Aquarell Illustration eines Krankenhauses mit Kirschblüten vor sonniger Stadtsilhouette im Frühling, Illustration mit AI erstellt.

HCA Healthcare (ISIN US40412C1018) was trading at EUR 415.00 at Lang & Schwarz on October 21, 2026 at 10:48 a.m. CEST. The next market test is the company report scheduled for October 27, 2026, when analysts expect USD 6.66 in earnings per share and USD 19.33 billion in revenue, according to MarketBeat.

What will the October report show?

The forecast points to a slower earnings period after a strong second quarter. MarketBeat reported that HCA generated USD 20.23 billion in second-quarter revenue, up 8.70 percent from the prior-year quarter, while earnings per share reached USD 7.59. The same source cited a consensus estimate of USD 7.56 for that period.

HCA's latest management outlook also gives investors a broad operating frame. In the second-quarter earnings call dated July 24, 2026, management guided to full-year revenue of USD 77.0 billion to USD 79.5 billion, adjusted EBITDA of USD 15.4 billion to USD 16.1 billion, and diluted earnings per share of USD 28.70 to USD 30.50, according to Yahoo Finance.

Three dates frame the stock

Chronology matters for the earnings setup. HCA reported its second-quarter results on July 24, 2026, TD Cowen raised its price target to USD 460.00 on October 12, 2026, and the company scheduled its third-quarter results for October 27, 2026, according to MarketBeat.

What dates matter next?

The next dated event is the third-quarter earnings release on October 27, 2026, before the market opens, followed by a conference call at 10:00 a.m. ET. The scheduled report will test whether HCA can sustain its second-quarter revenue growth while managing payer-mix pressure and elective-surgery softness.

Stock position before results

HCA Healthcare has a USD 100.8 billion market capitalization as of October 20, 2026, while its primary listing is on the NYSE. The company operates hospitals and outpatient facilities across the United States, giving its volume trends a direct role in the earnings discussion.

HCA Healthcare was trading at EUR 415.00 at Lang & Schwarz on October 21, 2026 at 10:48 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.